Another Psilocybin article

A psychedelics expert says he's 'absolutely sure' magic mushrooms will be approved for depression before 2027.

A small recent trial of psilocybin in people whose chronic depression had not responded to repeated attempts at treatment with medication suggested that this may be the case. While the trial, co-directed by Amanda Feilding, who founded the Beckley Foundation, was designed to determine only if the drug was safe, all of the study participants said at a one-week follow-up that they saw a significant decrease in symptoms. The majority said at a follow-up three months later that they continued to see a decrease in symptoms.
"We treated people who'd been suffering for 30 years, and they're getting better with a single dose," said Nutt, who was one of the authors of the study. "So that tells us this drug is doing something profound."